Valentina Scattolini

Dr. Valentina Scattolini

University of Padova
+1
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2016 in Diabetes
Verified
Journal Article
Open access
PDF file
Gian Paolo FadiniGian Paolo Fadini
Gian Paolo Fadini
LMLisa Menegazzo
Lisa Menegazzo
MRMauro Rigato
Mauro Rigato
VSValentina Scattolini
Valentina Scattolini
NPNicol Poncina
Nicol Poncina
AAAngelo Avogaro
Angelo Avogaro
Upon activation, neutrophils undergo histone citrullination by protein arginine deiminase (PAD)4, exocytosis of chromatin and enzymes as neutrophil extracellular traps (NETs), and death. In diabetes, neutrophils are primed to release NETs and die by NETosis. Although this process is a defense against infection, NETosis can damage tissue. Therefore, we examined the effect of NETosis on the healing of diabetic foot ulcers (DFUs). Using proteomics, we found that NET components were enriched in nonhealing human DFUs. In an independent validation cohort, a high concentration of neutrophil elastase in the wound was associated with infection and a subsequent worsening of the ulcer. NET components (elastase, histones, neutrophil gelatinase-associated lipocalin, and proteinase-3) were elevated in the blood of patients with DFUs. Circulating elastase and proteinase-3 were associated with infection, and serum elastase predicted delayed healing. Neutrophils isolated from the blood of DFU patients showed an increased spontaneous NETosis but an impaired inducible NETosis. In mice, skin PAD4 activity was increased by diabetes, and FACS detection of histone citrullination, together with intravital microscopy, showed that NETosis occurred in the bed of excisional wounds. PAD4 inhibition by Cl-amidine reduced NETting neutrophils and rescued wound healing in diabetic mice. Cumulatively, these data suggest that NETosis delays DFU healing.

22 June 2020 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
Anna UrciuoloAnna Urciuolo
Anna Urciuolo
IPIlaria Poli
Ilaria Poli
LBLuca Brandolino
Luca Brandolino
PRPaolo Raffa
Paolo Raffa
VSValentina Scattolini
Valentina Scattolini
NENicola Elvassore
Nicola Elvassore

15 March 2018 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
LMLisa Menegazzo
Lisa Menegazzo
VSValentina Scattolini
Valentina Scattolini
RCRoberta Cappellari
Roberta Cappellari
BBBenedetta Maria Bonora
Benedetta Maria Bonora
MAMattia Albiero
Mattia Albiero
Gian Paolo FadiniGian Paolo Fadini
Gian Paolo Fadini

30 May 2023 in Nature Communications
Verified
Journal Article
Open access
Anna UrciuoloAnna Urciuolo
Anna Urciuolo
GGGiovanni Giuseppe Giobbe
Giovanni Giuseppe Giobbe
YDYixiao Dong
Yixiao Dong
FMFederica Michielin
Federica Michielin
LBLuca Brandolino
Luca Brandolino
NENicola Elvassore
Nicola Elvassore
Three-dimensional hydrogel-based organ-like cultures can be applied to study development, regeneration, and disease in vitro. However, the control of engineered hydrogel composition, mechanical properties and geometrical constraints tends to be restricted to the initial time of fabrication. Modulation of hydrogel characteristics over time and according to culture evolution is often not possible. Here, we overcome these limitations by developing a hydrogel-in-hydrogel live bioprinting approach that enables the dynamic fabrication of instructive hydrogel elements within pre-existing hydrogel-based organ-like cultures. This can be achieved by crosslinking photosensitive hydrogels via two-photon absorption at any time during culture. We show that instructive hydrogels guide neural axon directionality in growing organotypic spinal cords, and that hydrogel geometry and mechanical properties control differential cell migration in developing cancer organoids. Finally, we show that hydrogel constraints promote cell polarity in liver organoids, guide small intestinal organoid morphogenesis and control lung tip bifurcation according to the hydrogel composition and shape.

16 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LTLuca De Toni
Luca De Toni
AGAndrea Garolla
Andrea Garolla
MMMassimo Menegazzo
Massimo Menegazzo
SMSabina Magagna
Sabina Magagna
ANAndrea Di Nisio
Andrea Di Nisio
CFCarlo Foresta
Carlo Foresta
The molecular bases of sperm thermotaxis, the temperature-oriented cell motility, are currently under investigation. Thermal perception relies on a subclass of the transient receptor potential [TRP] channels, whose member TRPV1 is acknowledged as the heat sensing receptor. Here we investigated the involvement of TRPV1 in human sperm thermotaxis. We obtained semen samples from 16 normozoospermic subjects attending an infertility survey programme, testis biopsies from 6 patients with testicular germ cell cancer and testis fine needle aspirates from 6 patients with obstructive azoospermia undergoing assisted reproductive technologies. Expression of TRPV1 mRNA was assessed by RT-PCR. Protein expression of TRPV1 was determined by western blot, flow cytometry and immunofluorescence. Sperm motility was assessed by Sperm Class Analyser. Acrosome reaction, apoptosis and intracellular-Ca2+ content were assessed by flow cytometry. We found that TRPV1 mRNA and protein were highly expressed in the testis, in both Sertoli cells and germ-line cells. Moreover, compared to no-gradient controls at 31°C or 37°C (Ctrl 31°C and Ctrl 37°C respectively), sperm migration towards a temperature gradient of 31–37°C (T gradient) in non-capacitated conditions selected a higher number of cells (14,9 ± 4,2×106 cells T gradient vs 5,1± 0,3×106 cells Ctrl 31°C and 5,71±0,74×106 cells Ctrl 37°C; P = 0,039). Capacitation amplified the migrating capability towards the T gradient. Sperms migrated towards the T gradient showed enriched levels of both TRPV1 protein and mRNA. In addition, sperm cells were able to migrate toward a gradient of capsaicin, a specific agonist of TRPV1, whilst capsazepine, a specific agonist of TRPV1, blocked this effect. Finally, capsazepine severely blunted migration towards T gradient without abolishing. These results suggest that TRPV1 may represent a facilitating mediator of sperm thermotaxis.

1 April 2019 in Diabetes
Verified
Journal Article
Closed access
PDF file
MAMattia Albiero
Mattia Albiero
Stefano CiciliotStefano Ciciliot
Stefano Ciciliot
STSerena Tedesco
Serena Tedesco
LMLisa Menegazzo
Lisa Menegazzo
MDMarianna D’aNna
Marianna D’aNna
Gian Paolo FadiniGian Paolo Fadini
Gian Paolo Fadini
Diabetes impairs the mobilization of hematopoietic stem/progenitor cells (HSPCs) from the bone marrow (BM), which can worsen the outcomes of HSPC transplantation and of diabetic complications. In this study, we examined the oncostatin M (OSM)–p66Shc pathway as a mechanistic link between HSPC mobilopathy and excessive myelopoiesis. We found that streptozotocin-induced diabetes in mice skewed hematopoiesis toward the myeloid lineage via hematopoietic-intrinsic p66Shc. The overexpression of Osm resulting from myelopoiesis prevented HSPC mobilization after granulocyte colony-stimulating factor (G-CSF) stimulation. The intimate link between myelopoiesis and impaired HSPC mobilization after G-CSF stimulation was confirmed in human diabetes. Using cross-transplantation experiments, we found that deletion of p66Shc in the hematopoietic or nonhematopoietic system partially rescued defective HSPC mobilization in diabetes. Additionally, p66Shc mediated the diabetes-induced BM microvasculature remodeling. Ubiquitous or hematopoietic restricted Osm deletion phenocopied p66Shc deletion in preventing diabetes-associated myelopoiesis and mobilopathy. Mechanistically, we discovered that OSM couples myelopoiesis to mobilopathy by inducing Cxcl12 in BM stromal cells via nonmitochondrial p66Shc. Altogether, these data indicate that cell-autonomous activation of the OSM-p66Shc pathway leads to diabetes-associated myelopoiesis, whereas its transcellular hematostromal activation links myelopoiesis to mobilopathy. Targeting the OSM-p66Shc pathway is a novel strategy to disconnect mobilopathy from myelopoiesis and restore normal HSPC mobilization.